KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Amortization - Intangibles (2019 - 2025)

Historic Amortization - Intangibles for Bristol Myers Squibb (BMY) over the last 7 years, with Q3 2025 value amounting to $831.0 million.

  • Bristol Myers Squibb's Amortization - Intangibles fell 6546.13% to $831.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 billion, marking a year-over-year decrease of 5575.76%. This contributed to the annual value of $8.9 billion for FY2024, which is 193.43% down from last year.
  • Bristol Myers Squibb's Amortization - Intangibles amounted to $831.0 million in Q3 2025, which was down 6546.13% from $830.0 million recorded in Q2 2025.
  • Bristol Myers Squibb's Amortization - Intangibles' 5-year high stood at $2.5 billion during Q2 2021, with a 5-year trough of $830.0 million in Q1 2025.
  • For the 5-year period, Bristol Myers Squibb's Amortization - Intangibles averaged around $2.1 billion, with its median value being $2.4 billion (2024).
  • Per our database at Business Quant, Bristol Myers Squibb's Amortization - Intangibles skyrocketed by 1012.27% in 2021 and then crashed by 6564.57% in 2025.
  • Bristol Myers Squibb's Amortization - Intangibles (Quarter) stood at $2.4 billion in 2021, then fell by 3.06% to $2.3 billion in 2022, then fell by 2.77% to $2.3 billion in 2023, then fell by 25.68% to $1.7 billion in 2024, then tumbled by 50.92% to $831.0 million in 2025.
  • Its Amortization - Intangibles stands at $831.0 million for Q3 2025, versus $830.0 million for Q2 2025 and $830.0 million for Q1 2025.